Encompassing all Executive through Board Positions in Life Sciences

Director of the Board

Yes

Chief Executive Officer

Yes

Chief Business Officer

Leading publicly traded biopharmaceutical stem cell company.

No

Chairman of the Board

Yes

Chief Financial Officer

Formerly Aastrom Biosciences

Yes

Chief Operating Officer

Yes

Chief Scientific Officer

Leading publicly traded monoclonal antibody & oncology company

No

Executive Vice President, Orthopedics and Chief Operating Officer

Formerly BioMimetic Therapeutics, Inc.

Yes
See More

In The News

https://www.biospace.com/policy/big-pharma-appears-to-be-unfazed-by-ira-drug-price-negotiations

The European Medicines Agency’s Committee for Medicinal Products for Human Use found that Leqembi’s benefits do not outweigh the risks of severe side effects associated with the treatment.

https://www.biospace.com/drug-development/eu-regulatory-panel-recommends-against-approval-of-eisai-biogens-leqembi-for-alzheimers
https://www.biospace.com/business/argenxs-strong-q2-sales-reinvigorate-clinical-plans-for-vyvgart
https://www.biospace.com/FDA/fda-adcomm-calls-for-changes-in-perioperative-lung-cancer-trials
https://www.biospace.com/drug-development/roche-to-accelerate-development-of-obesity-assets-from-2-7b-carmot-buy

Bristol Myers Squibb on Friday reported strong second-quarter results, led by the blood thinner Eliquis and cancer therapy Opdivo, as it looks to cut $1.5 billion in costs by 2025.

https://www.biospace.com/business/bms-gets-q2-beat-raises-full-year-guidance-as-cost-cutting-initiative-continues

American Academy of Pain Medicine (AAPM)
Scottsdale, AZ March 07-10

American Association for Cancer Research Annual Meeting (AACR)
San Diego, CA April 05-10

American Society for Transplantation and Cellular Therapy
San Antonio, TX February 21-25

BofA 2024 Healthcare Conference
Las Vegas, NV May 14-16

Needham & Co. Annual Healthcare Conference
Virtual April 08-11

36th Annual Roth Conference
Dana Point, CA March 17-19

See More Events

Read More Articles